Fermenta Biotech Ltd.

₹339

+ 18.30 (5.71%)

04:01 pm - close price

BSE: FERMENTA

NSE:

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 26.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 26.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 21.97Good: 20

✅

Current Ratio

Bad: 1Current: 1.50Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 23.93Good: 15

✅

Debt to Total Assets

Bad: 1Current: 17.28Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 26.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 26.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 21.97Good: 20

✅

Current Ratio

Bad: 1Current: 1.50Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 23.93Good: 15

✅

Debt to Total Assets

Bad: 1Current: 17.28Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	82.45	56.91	98.97	97.34	78.13
Expenditure+	71.51	70.83	73.85	91.97	77.33
Other Income+	2.01	1.90	2.52	5.38	2.82
Operating Profit	10.94	-13.92	25.12	5.37	0.81
Interest	4.78	3.69	5.19	3.39	3.43
Depreciation and Amortization	5.95	5.93	6.38	6.46	6.12
Profit Before Tax	2.21	-29.07	16.07	0.91	-5.93
Tax+	0.00	0.00	6.08	8.05	0.00
Net Profit	2.21	-29.07	9.99	-7.14	-5.93

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	37728.88	39851.57	34994.09	33566.19	46947.73
Operational Expenses+	29471.15	33628.51	33174.53	30777.22	35897.64
Operating Profit	8257.73	6223.06	1819.56	2788.97	11050.09
Other Income	836.52	825.20	859.59	1180.83	1181.85
OPM %	21.89	15.62	5.20	8.31	23.54
Depreciation and Amortisation	2030.84	2556.16	2824.75	2471.92	2421.83
Interest	1900.35	1797.79	2137.24	1742.54	1489.33
Profit Before Tax	5163.06	2694.31	-5130.52	-987.30	8320.78
Tax	910.02	1188.25	298.22	168.02	680.50
Net Profit	4550.66	1544.71	-5107.52	-2305.98	7686.18

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	72179.79	75334.93	63976.09	55626.54	63295.42
Liabilities+	72179.79	75334.93	63976.09	55626.54	63295.42

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	6259.72	4344.12	11610.83	10534.59	4090.20
Cash from Investing Activity	-4154.98	-2603.76	-5540.85	-1549.74	-15.95
Cash from Financing Activity	-114.32	-2157.84	-4137.99	-9085.18	-5086.58
Net Cash Flow	1990.42	-417.48	1931.99	-100.33	-1012.33
Opening Cash & Cash Equivalents	-1822.44	229.13	-161.42	1775.46	1675.13
Closing Cash & Cash Equivalents	229.13	-188.35	1775.46	1675.13	662.80

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	64.09	64.09	64.09	64.09	62.06	62.06	62.06	62.06	62.06	62.06
Public+	35.91	35.91	35.91	35.91	37.94	37.94	37.94	37.94	37.94	37.94
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	14139	13760	12845	12930	12922	13221	14589	15178	15150	15721

Corporate Actions

136 events in the last 3 years

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	37728.88	39851.57	34994.09	33566.19	46947.73
Operational Expenses+	29471.15	33628.51	33174.53	30777.22	35897.64
Operating Profit	8257.73	6223.06	1819.56	2788.97	11050.09
Other Income	836.52	825.20	859.59	1180.83	1181.85
OPM %	21.89	15.62	5.20	8.31	23.54
Depreciation and Amortisation	2030.84	2556.16	2824.75	2471.92	2421.83
Interest	1900.35	1797.79	2137.24	1742.54	1489.33
Profit Before Tax	5163.06	2694.31	-5130.52	-987.30	8320.78
Tax	910.02	1188.25	298.22	168.02	680.50
Net Profit	4550.66	1544.71	-5107.52	-2305.98	7686.18

Ratios

Reported EPS

Bad: 2Current: 26.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 26.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 21.97Good: 20

✅

Current Ratio

Bad: 1Current: 1.50Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 23.93Good: 15

✅

Debt to Total Assets

Bad: 1Current: 17.28Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 26.35Good: 5

✅

Adjusted EPS

Bad: 3Current: 26.35Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 21.97Good: 20

✅

Current Ratio

Bad: 1Current: 1.50Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 23.93Good: 15

✅

Debt to Total Assets

Bad: 1Current: 17.28Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	82.45	56.91	98.97	97.34	78.13
Expenditure+	71.51	70.83	73.85	91.97	77.33
Other Income+	2.01	1.90	2.52	5.38	2.82
Operating Profit	10.94	-13.92	25.12	5.37	0.81
Interest	4.78	3.69	5.19	3.39	3.43
Depreciation and Amortization	5.95	5.93	6.38	6.46	6.12
Profit Before Tax	2.21	-29.07	16.07	0.91	-5.93
Tax+	0.00	0.00	6.08	8.05	0.00
Net Profit	2.21	-29.07	9.99	-7.14	-5.93

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	64.09	64.09	64.09	64.09	62.06	62.06	62.06	62.06	62.06	62.06
Public+	35.91	35.91	35.91	35.91	37.94	37.94	37.94	37.94	37.94	37.94
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	14139	13760	12845	12930	12922	13221	14589	15178	15150	15721

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	72179.79	75334.93	63976.09	55626.54	63295.42
Liabilities+	72179.79	75334.93	63976.09	55626.54	63295.42

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	6259.72	4344.12	11610.83	10534.59	4090.20
Cash from Investing Activity	-4154.98	-2603.76	-5540.85	-1549.74	-15.95
Cash from Financing Activity	-114.32	-2157.84	-4137.99	-9085.18	-5086.58
Net Cash Flow	1990.42	-417.48	1931.99	-100.33	-1012.33
Opening Cash & Cash Equivalents	-1822.44	229.13	-161.42	1775.46	1675.13
Closing Cash & Cash Equivalents	229.13	-188.35	1775.46	1675.13	662.80

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Fermenta Biotech Ltd.

₹339

+ 18.30 (5.71%)

04:01 pm - close price

BSE: FERMENTA

NSE:

Industry: Pharmaceuticals & Drugs

House: Private

Overview

Corporate Actions

136 events in the last 3 years